Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.7.0.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 8,350 $ 14,006
Receivables 87 3,587
Prepaid expenses and other current assets 317 237
Total current assets 8,754 17,830
Property and equipment, net 660 837
Total assets 9,414 18,667
Current liabilities:    
Accounts payable 928 3,015
Accrued clinical trials expenses 385 1,387
Other accrued liabilities 556 455
Total current liabilities 1,869 4,857
Warrant liabilities 7 619
Total liabilities 1,876 5,476
Commitments and contingencies
Stockholders’ equity:    
Common stock, at amounts paid-in 297,855 297,855
Additional paid-in capital 25,103 24,300
Accumulated deficit (315,420) (308,964)
Total stockholders’ equity 7,538 13,191
Total liabilities and stockholders' equity $ 9,414 $ 18,667